title: Evolving provider payment models and patient access to innovative medical technology.
abstract: Abstract Objective: To investigate the evolving use and expected impact of pay-for-performance (P4P) and risk-based provider reimbursement on patient access to innovative medical technology.
  
  
  METHODS
  Structured interviews with leading private payers representing over 110 million commercially-insured lives exploring current and planned use of P4P provider payment models, evidence requirements for technology assessment and new technology coverage, and the evolving relationship between the two topics.
  
  
  RESULTS
  Respondents reported rapid increases in the use of P4P and risk-sharing programs, with roughly half of commercial lives affected 3 years ago, just under two-thirds today, and an expected three-quarters in 3 years. All reported well-established systems for evaluating new technology coverage. Five of nine reported becoming more selective in the past 3 years in approving new technologies; four anticipated that in the next 3 years there will be a higher evidence requirement for new technology access. Similarly, four expected it will become more difficult for clinically appropriate but costly technologies to gain coverage. All reported planning to rely more on these types of provider payment incentives to control costs, but didn't see them as a substitute for payer technology reviews and coverage limitations; they each have a role to play.
  
  
  CONCLUSIONS
  Interviews limited to nine leading payers with models in place; self-reported data.
  
  
  CONCLUSIONS
  Likely implications include a more uncertain payment environment for providers, and indirectly for innovative medical technology and future investment, greater reliance on quality and financial metrics, and increased evidence requirements for favorable coverage and utilization decisions. Increasing provider financial risk may challenge the traditional technology adoption paradigm, where payers assumed a 'gatekeeping' role and providers a countervailing patient advocacy role with regard to access to new technology. Increased provider financial risk may result in an additional hurdle to the adoption of new technology, rather than substitution of provider- for payer-based gatekeeping.
authors.affiliation: Analysis Group, Inc. , Boston, MA , USA.
authors.forename: Genia
authors.initials: G
authors.lastname: Long
authors.forename: Richard
authors.initials: R
authors.lastname: Mortimer
authors.forename: Geoffrey
authors.initials: G
authors.lastname: Sanzenbacher
mesh_terms: D020811:Biomedical Technology; D004389:Durable Medical Equipment; D005102:Health Expenditures; D006297:Health Services Accessibility; D006801:Humans; D007407:Interviews as Topic; D008329:Managed Care Programs / Q000191:economics; D036301:Qualitative Research; D011787:Quality of Health Care / Q000191:economics; D012052:Reimbursement, Incentive
keywords: Durable medical equipment; Health; Healthcare reform; Insurance; Managed care programs; Medical economics; Reimbursement; Technology assessment